Keyword Analysis & Research: dharmacon ge


Keyword Analysis


Keyword Research: People who searched dharmacon ge also searched

Frequently Asked Questions

What happened to GE Healthcare Dharmacon?

In July 2015, GE Healthcare Dharmacon launched synthetic crRNA and lentiviral sgRNA pre-designed with a functionally validated algorithm against entire human, mouse and rat genomes. In July 2017, UK firm Horizon Discovery reached an agreement to acquire Dharmacon from GE Healthcare for a total consideration of $85 million.

Why choose Gege Dharmacon RNA synthesis?

GE Dharmacon RNA synthesis chemistry provides researchers with high-quality custom single-stranded RNA, siRNA, synthetic sgRNA, and microRNA with an extensive range of modifications, synthesis scales, and purification choices. Also available are DNA only oligos, as well as RNA:DNA hybrids.

Who owns Dharmacon?

In July 2017, UK firm Horizon Discovery reached an agreement to acquire Dharmacon from GE Healthcare for a total consideration of $85 million. The acquisition is expected to complement Horizon's portfolio of gene editing products and engineered cell lines.

What does Dharmacon do?

Based in Lafayette, CO, Dharmacon is an indirect wholly owned subsidiary of General Electric that has grown into a leading provider of RNA interference (RNAi) products, with a gene-editing product portfolio specializing in CRISPR reagents and arrayed libraries.


Search Results related to dharmacon ge on Search Engine